#VisualAbstract: Switch to fulvestrant and palbociclib may improve survival in patients with advanced breast cancer and ESR1 mutation
Click to read this study in The Lancet Oncology.
Click to read this study in The Lancet Oncology.
1. In this randomized controlled trial, the post-test fatigue score was significantly lower in those who received spiritual care, compared ...
1. The United States regimen had greater event-free survival and less associated febrile neutropenia compared to the European regimen. 2. ...
1. The Bazett formula showed greater CTCAE grading than either Fridericia or Framingham formulae in 40.9% of total ECGs. 2. ...
Click to read this study in the Journal of Clinical Oncology.
Click to read this study in the Journal of Clinical Oncology.
Click to read this study in The Lancet Oncology.
Click to read this study in Journal of Clinical Oncology.
1. Patients with resectable non-small cell lung cancer (NSCLC) receiving neoadjuvant nivolumab in addition to platinum-based chemotherapy demonstrated longer survival ...
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.